{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:16:28Z","timestamp":1648516588846},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T00:00:00Z","timestamp":1321660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00296-011-2228-9","type":"journal-article","created":{"date-parts":[[2011,11,18]],"date-time":"2011-11-18T00:55:00Z","timestamp":1321577700000},"page":"805-808","source":"Crossref","is-referenced-by-count":2,"title":["Anti-microtubule organizing center with microtubule by autoimmune target test is also useful serological marker in rheumatoid arthritis evaluation"],"prefix":"10.1007","volume":"33","author":[{"given":"Duck-An","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Think-You","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,19]]},"reference":[{"key":"2228_CR1","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"2228_CR2","first-page":"S364","volume":"44","author":"SG Kim","year":"2001","unstructured":"Kim SG, Jung KY, Suh HS, Choe JY, Chung SH, Kim CG, Song YH (2001) Is it feasible to adopt a commercialized APF kit (IT-APF\u2122) as a routine diagnostic tool for rheumatoid arthritis? Arthritis Rheum 44:S364","journal-title":"Arthritis Rheum"},{"key":"2228_CR3","first-page":"1944","volume":"34","author":"DA Kim","year":"2007","unstructured":"Kim DA, Jearn LH, Kim TY (2007) Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis. J Rheumatol 34:1944\u20131945","journal-title":"J Rheumatol"},{"key":"2228_CR4","first-page":"S255","volume":"38","author":"TY Kim","year":"1995","unstructured":"Kim TY, Chang SY, Kim SY (1995) New autoantibodies (anti-MTOC) detected by macrophage cell line (IT-1) in rheumatoid arthritis. Arthritis Rheum 38:S255","journal-title":"Arthritis Rheum"},{"key":"2228_CR5","first-page":"S350","volume":"26","author":"TY Kim","year":"2006","unstructured":"Kim TY (2006) A external quality assurance program for autoimmune tests. Kor J Lab Med 26:S350\u2013S352","journal-title":"Kor J Lab Med"},{"key":"2228_CR6","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1515\/CCLM.2010.215","volume":"48","author":"LH Jearn","year":"2010","unstructured":"Jearn LH, Kim TY (2010) Should the external quality assessment sample of antinuclear antibodies be of a typical monospecific pattern? Clin Chem Lab Med 48:1189\u20131190","journal-title":"Clin Chem Lab Med"},{"key":"2228_CR7","first-page":"1282","volume":"18","author":"K Aho","year":"1991","unstructured":"Aho K, Heli\u00f6vaara M, Maatela J, Tuomi T, Palosuo T (1991) Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 18:1282\u20131284","journal-title":"J Rheumatol"},{"key":"2228_CR8","first-page":"1278","volume":"20","author":"K Aho","year":"1993","unstructured":"Aho K, von Essen R, Kurki P, Palosuo T, Heli\u00f6vaara M (1993) Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol 20:1278\u20131281","journal-title":"J Rheumatol"},{"key":"2228_CR9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380\u2013386","journal-title":"Arthritis Rheum"},{"key":"2228_CR10","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3899\/jrheum.100399","volume":"37","author":"J Zhao","year":"2010","unstructured":"Zhao J, Liu X, Wang Z, Liu R, Li Z (2010) Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis? J Rheumatol 37:2462\u20132465","journal-title":"J Rheumatol"},{"key":"2228_CR11","first-page":"109","volume":"16","author":"TY Kim","year":"1994","unstructured":"Kim TY, Oh J, Seo IH, Kim DA, Chang SY, Yoo DH, Kim SY (1994) Antiperinuclear factor: a new marker antibody for rheumatoid arthritis. Korean J Immunol 16:109\u2013113","journal-title":"Korean J Immunol"},{"key":"2228_CR12","first-page":"S317","volume":"37","author":"TY Kim","year":"1994","unstructured":"Kim TY, Chang SY, Kim SY (1994) A new substrate (IT-1) for the antinuclear antibody (ANA) test. Arthritis Rheum 37:S317","journal-title":"Arthritis Rheum"},{"key":"2228_CR13","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/rheumatology\/keq442","volume":"50","author":"Y Kaneko","year":"2011","unstructured":"Kaneko Y, Kuwana M, Kameda H, Takeuchi T (2011) Sensitivity and specificity of 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford) 50:1268\u20131274","journal-title":"Rheumatology (Oxford)"},{"key":"2228_CR14","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3899\/jrheum.080796","volume":"36","author":"X Liu","year":"2009","unstructured":"Liu X, Jia R, Zhao J, Li Z (2009) The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. J Rheumatol 36:1136\u20131142","journal-title":"J Rheumatol"},{"key":"2228_CR15","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3899\/jrheum.090118","volume":"36","author":"LH Jearn","year":"2009","unstructured":"Jearn LH, Kim DA, Kim TY (2009) Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus. J Rheumatol 36:1833\u20131834","journal-title":"J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2228-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2228-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2228-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:21:34Z","timestamp":1559028094000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2228-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,19]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2228"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2228-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,19]]}}}